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Introduction
The Muckle-Wells syndrome (MWS) is a rare inherited
disease and belongs to the group of cryopyrin-associated
periodic syndromes (CAPS). Recurrent fever attacks,
myalgia, arthralgia, urticarial rash, headache, conjunctivitis,
sensorineural deafness and a severe fatigue syndrome
are the typical symptoms of MWS. Due to an unregu-
lated production of IL1 a continuous formation of
serum amyloid leads ultimately to the development of
AA-myloidosis, which is life-threatening and in some
cases the fatal complication of MWS.
Case Report
Here we report the three years follow up on a 34-year old
female patient with Muckle-Wells syndrome and biopsy
proven systemic AA amyloidosis and end stage renal
disease. After renal transplantation therapy with canakinu-
mab subcutaneously in a dosage of 150 mg every eight
weeks was continued in combination with the immuno-
suppressive therapy.
Discussion
Before and after renal transplantation the patient had a
very good response to canakinumab with low activity in
inflammation markers with an improved quality of life.
Over the period of three years the triple immunosuppres-
sive therapy (CSA, MMF, Prednisone) in combination
with canakinumab has had no negative effect on activity of
MWS and no pharmacological interactions between medi-
cation were observed. Even 3 years after renal transplanta-
tion, the patient remains an excellent kidney function
without proteinuria. There are no signs of recurrence of
AA-amyloidosis in the transplanted kidney.
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